132 related articles for article (PubMed ID: 10598872)
1. In situ localization of S-phase-specific histone (H3) mRNA in Bowen's disease.
Murakami M; Mizoguchi Y; Horibe Y; Komori K; Hori H; Kasahara M
APMIS; 1999 Nov; 107(11):1005-12. PubMed ID: 10598872
[TBL] [Abstract][Full Text] [Related]
2. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
[TBL] [Abstract][Full Text] [Related]
3. Use of in situ detection of histone mRNA in the assessment of epidermal proliferation: comparison with the Ki67 antigen and BrdU incorporation.
Smith MD; Healy E; Thompson V; Morley A; Rees JL
Br J Dermatol; 1995 Mar; 132(3):359-66. PubMed ID: 7718451
[TBL] [Abstract][Full Text] [Related]
4. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
Hughes JH; Robinson RA
Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA.
Muskhelishvili L; Latendresse JR; Kodell RL; Henderson EB
J Histochem Cytochem; 2003 Dec; 51(12):1681-8. PubMed ID: 14623936
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
8. Patterns of basal cell keratin 14 expression in Bowen's disease: a possible marker for tumour progression.
Komine M; Okinaga M; Takeda F; Nashiro K; Kikuchi K; Murakami T; Soma Y; Tamaki K
Br J Dermatol; 2001 Aug; 145(2):223-8. PubMed ID: 11531783
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of keratins and involucrin in solar keratosis and Bowen's disease.
Ichikawa E; Watanabe S; Otsuka F
Am J Dermatopathol; 1995 Apr; 17(2):151-7. PubMed ID: 8600780
[TBL] [Abstract][Full Text] [Related]
10. Histopathological assessment of localized proliferation in cases of Bowen's disease using immunostaining and a laser cytometer.
Murakami M; Hashimoto Y; Tsukinoki K; Matsunaga K; Mizoguchi Y; Horibe Y; Tashiro K; Watanabe Y; Kasahara M
Arch Dermatol Res; 1998 Aug; 290(8):435-40. PubMed ID: 9763306
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA) and p53 protein expression in Bowen's disease.
Takata M; Matsui Y
J Dermatol; 1994 Dec; 21(12):947-52. PubMed ID: 7868767
[TBL] [Abstract][Full Text] [Related]
12. The proliferative properties of tumor cells differentially correlate with the host immune responses in anogenital Bowen's disease.
Duan H; Imafuku S; Yonemitsu Y; Yasumoto S; Koga T; Nagae S; Kiryu H; Imayama S; Sueishi K; Hori Y; Furue M
J Dermatol Sci; 1998 May; 20(1):53-62. PubMed ID: 10342748
[TBL] [Abstract][Full Text] [Related]
13. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
14. Expression of proliferation-associated proteins (proliferating cell nuclear antigen and Ki-67 antigen) in Bowen's disease.
Baum HP; Meurer I; Unteregger G
Br J Dermatol; 1994 Aug; 131(2):231-6. PubMed ID: 7917988
[TBL] [Abstract][Full Text] [Related]
15. Significance of mitotic cells or clumping cells in p53 immunopositivity of Bowen's disease.
Ura H; Nashiro K; Kikuchi K; Imakado S; Matsukawa A; Furue M
Dermatology; 1997; 194(1):87-8. PubMed ID: 9031804
[No Abstract] [Full Text] [Related]
16. Expression of CD40 and CD40 ligand in Bowen's disease and squamous cell carcinoma.
Amo Y; Ohta Y; Hamada Y; Tatsuta M; Katsuoka K
Eur J Dermatol; 2000 Aug; 10(6):439-42. PubMed ID: 10980464
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus infection in actinic keratosis and bowen's disease: comparative study with expression of cell-cycle regulatory proteins p21(Waf1/Cip1), p53, PCNA, Ki-67, and Bcl-2 in positive and negative lesions.
Mitsuishi T; Kawana S; Kato T; Kawashima M
Hum Pathol; 2003 Sep; 34(9):886-92. PubMed ID: 14562284
[TBL] [Abstract][Full Text] [Related]
18. Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease.
Kawakami T; Soma Y; Mizoguchi M; Saito R
Dermatology; 2001; 202(1):9-15. PubMed ID: 11244221
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 and p53 expression in cutaneous Bowen's disease: an immunohistochemical study of fixed-embedded tissue sections.
Szekeres G; De Giacomoni P
Acta Derm Venereol; 1994 Mar; 74(2):95-7. PubMed ID: 7911636
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 protein is expressed in Bowen's disease.
Sim CS; Slater SD; McKee PH
Am J Dermatopathol; 1992 Jun; 14(3):195-9. PubMed ID: 1510215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]